Westfield Capital Management CO LP Rocket Pharmaceuticals, Inc. Transaction History
Westfield Capital Management CO LP
- $21.6 Billion
- Q4 2024
A detailed history of Westfield Capital Management CO LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 4,714,610 shares of RCKT stock, worth $38.5 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
4,714,610
Previous 4,493,833
4.91%
Holding current value
$38.5 Million
Previous $83 Million
28.6%
% of portfolio
0.27%
Previous 0.39%
Shares
25 transactions
Others Institutions Holding RCKT
# of Institutions
243Shares Held
94.3MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$145 Million3.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$53.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$50.6 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$42.5 Million1.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.12MShares$33.7 Million0.01% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $618M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...